Positive outcomes of Phase 1 study for locally advanced/recurrent breast cancer of KORTUC presented at JASTRO

  • R&D

The results of the Phase 1 study in locally advanced breast cancer was presented at JASTRO* (Japanese Society for Radiation Oncology) in Nagoya by Dr. Navita Somaiah, Consultant Clinical Oncologist at the Royal Marsden Hospital, UK and chief investigator of the study.

Further information can be found below

*: Established in 1988, JASTRO is a professional organization in Japan with 4,090 members consisting mainly of radiation oncologists. Its mission is to contribute to the development of academic and scientific knowledge and technology related to therapeutic radiation, by engaging in collaborations and promotion of radiation oncology and related research